Pheiron is an applied research lab dedicated to biological alpha: knowing what biology will work in humans early enough to change the outcome of a drug program.
Today we work with scientists and capital allocators to underwrite biology and structure portfolios around programs with the highest probability of success. We see replacing human biological intuition with calibrated, quantitative models as an inevitable requirement towards a world without disease.
